John Hancock Exchange-Traded Fund Trust has officially filed a certification under Rule 497(j) with the U.S. Securities and Exchange Commission. This filing indicates that the form of prospectus and the statement of additional information for the John Hancock International Dynamic Growth Select ETF remain unchanged from previous versions. This stability is significant for investors and reflects the company's adherence to regulatory requirements.
The filing, dated October 27, 2026, is an important step for John Hancock, which is known for its investment management services. The company operates within the investment sector, focusing on exchange-traded funds (ETFs) that cater to various investment strategies.
According to the filing, "On behalf of the Trust, pursuant to paragraph (j) of Rule 497 under the Securities Act of 1933, please accept this letter as notice that the form of Prospectus and the form of Statement of Additional Information for the Fund that would have been filed... would not have differed from the Prospectus and Statement of Additional Information... dated October 23, 2026." This statement confirms that there are no changes to the previously filed documents.
This filing may have implications for investors and stakeholders in the ETF market. By maintaining consistency in its offerings, John Hancock aims to instill confidence among its investors and partners. The investment community, particularly those focused on ETFs, will likely take note of this filing as it underscores the company's commitment to transparency and regulatory compliance.
The filing does not say what happens next, leaving some uncertainty about future actions or developments from John Hancock Exchange-Traded Fund Trust.
Read Next
Jefferies CEO Handler Reports Stock Transactions in SEC Filing
Brophy Michael Burkes sells 3,084 shares of Natera stock
Glenbrook Capital Management Boosts Stake in SenesTech
OS Therapies grants stock options to Chief Medical Officer
Belite Bio CEO Lin Yu-Hsin Vests 5,000 Shares
Chen Wan-Shan Reports Share Transaction for Belite Bio






